The Cgrp Inhibitor Market is on a trajectory for significant growth, projected to reach approximately 9.64 billion USD by 2035, marking an impressive compound annual growth rate (CAGR) of 12.33%. This growth is primarily driven by an increasing demand for effective migraine treatments and the rising prevalence of migraine disorders in North America, which is currently the largest market. The...